DCM
CGON icon

Driehaus Capital Management’s CG Oncology CGON Stock Holding History

Driehaus Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-999,623
Closed -$67.7M – 371
2026
Q1 		$67.7M Buy
+999,623
New +$56.6M 0.5% 57
2025
Q1 		– Sell
-197,937
Closed -$5.68M – 413
2024
Q4 		$5.68M Sell
197,937
-2,046
-1% -$70K 0.05% 287
2024
Q3 		$7.55M Buy
199,983
+93,032
+87% +$3.26M 0.06% 251
2024
Q2 		$3.38M Sell
106,951
-1,006
-0.9% -$34.9K 0.03% 273
2024
Q1 		$4.74M Buy
+107,957
New +$4.41M 0.05% 282

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Driehaus Capital Management's CGON Position: Q2 2026 in Review

Driehaus Capital Management sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 999,623 shares — an estimated $67.7M sold.

Driehaus Capital Management first reported a position in CGON in Q1 2024 and held it in 5 quarters. The position peaked at $67.7M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Driehaus Capital Management reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 999,623 CG Oncology shares in Q2 2026, an estimated $67.7M.
  • Driehaus Capital Management first reported a position in CG Oncology in Q1 2024 and held it in 5 quarters.
  • Driehaus Capital Management's CG Oncology position peaked at $67.7M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.